Company Insights

IFF customer relationships

Explore interactive graphBrowse insights index
IFF customer relationship map

IFF’s customer footprint after the soy divestiture — what investors should know

International Flavors & Fragrances (IFF) manufactures flavors, fragrances and cosmetic actives and monetizes through global ingredient sales to food, beverage, personal care and consumer packaged goods manufacturers, supplemented by selective services and transition agreements tied to divestitures. The company converts product innovation and scale into recurring ingredient sales while selectively pruning non-core commodity businesses to sharpen margins and capital allocation. Investors should view recent asset sales and customer composition as deliberate portfolio repositioning toward higher-margin specialty ingredients and away from bulk agricultural commodities. For more background on counterparty exposures and relationship monitoring, visit https://nullexposure.com/.

What changed: Bunge completed the buy of several soy assets

IFF completed a strategic divestiture of its soy protein concentrate, lecithin and soy crush businesses to Bunge, removing commodity-facing operations from the IFF footprint and transferring associated customer flows to an agricultural processor. According to a BizWire press release published March 2, 2026, Bunge announced the closing of the acquisition. Market commentary and sector press confirmed the transaction and framed it as part of IFF’s ongoing portfolio simplification in FY2026.

All reported customer relationships (concise summaries)

  • Bunge Global SA — News outlets reported that Bunge acquired IFF’s soy protein concentrate, lecithin and soy crush businesses, completing the transfer of those commercial relationships and associated product lines. MarketScreener captured the transaction announcement on March 10, 2026.
    Source: MarketScreener, March 10, 2026.

  • Bunge Global SA — Financial commentary noted the acquisition was finalized and analysts discussed the implications for Bunge’s scale in specialty soy products and for IFF’s refocus on higher-margin ingredients. The Finviz roundup referenced analyst takes on the deal on March 10, 2026.
    Source: Finviz news summary, March 10, 2026.

  • Bunge — A corporate press release carried on FinancialContent/BizWire stated that Bunge “today announced the closing” of the soy businesses acquired from IFF, confirming the legal and operational completion of the sale. This item is dated March 2, 2026.
    Source: BizWire press release via FinancialContent, March 2, 2026.

  • Bunge — In IFF’s Q4 2025 earnings discussion the company recapped divestitures including the announced sale of soy crush, concentrates and lecithin to Bunge and positioned these moves within broader portfolio simplification. That language comes from IFF’s Q4 2025 earnings call transcript.
    Source: Q4 2025 earnings call transcript (distributed March 2026).

  • Bunge Global SA — Trade press covering the grains industry reported on the March 2, 2026 closing and described the transferred assets and the customer relationships that will now operate under Bunge’s platform. This coverage underscored the operational handoff in FY2026.
    Source: World-Grain industry report, March 2026.

What the relationship shift means for IFF’s customer profile

The sale to Bunge is not an isolated divestiture; it reflects a structural move away from lower-margin, commodity-facing customers and toward formulators and branded manufacturers. The transferred soy and lecithin businesses historically served grain processors and other bulk buyers — relationships now owned by a dedicated agricultural processor. IFF retains its core roles supplying flavors, fragrances and cosmetic actives to large consumer-products manufacturers and thousands of smaller customers.

Operating-model constraints and what they signal

IFF’s disclosed customer mix and related constraints offer clear signals about how the company contracts and where counterparty risk concentrates:

  • Broad base, high small-customer penetration. IFF reported approximately 18,300 customers, with roughly 67% small and mid-sized companies based on 2024 sales. This breadth implies a transactional revenue component and high customer-service demands across many low-volume accounts. This is a company-level signal about customer fragmentation and operational reach.

  • Material concentration among large customers. The company’s 25 largest customers accounted for ~33% of sales in aggregate in 2024, indicating significant revenue concentration and the importance of maintaining strategic supplier status with large multinationals. This increases commercial negotiation leverage on a small set of counterparties.

  • Geographic diversification reduces single-country exposure. North America, EMEA, Greater Asia and Latin America all recorded substantial sales, with U.S. representing ~28% of sales and no other single country exceeding 10% of sales. The global footprint reduces single-country demand risk but raises execution complexity and currency exposure.

  • Mixed relationship roles: manufacturer-facing and seller. IFF’s customers are principally manufacturers (food, beverage, personal care, CPG) and IFF emphasizes being on strategic customers’ core supplier lists, which signals contract-level stickiness and sales pipeline access. This is a company-level signal about commercial maturity and criticality to customers’ formulations.

  • Transition services indicate structured divestiture execution. IFF has used transition services agreements following disposals, recognizing modest transition-services income and continuing to support buyers for a defined period. This highlights disciplined exit mechanics and temporary service-provider engagements during portfolio reshaping.

Collectively, these signals show a contracting posture that blends transactional breadth with strategic large-account dependence, a matured supplier position with high operational demands across regions, and ongoing de-risking via divestitures.

Investment implications — risk, return, and next catalysts

  • Earnings quality should improve as IFF eliminates commodity volatility by selling soy crush and lecithin operations, narrowing exposure to low-margin flows and improving margin mix. This supports the forward P/E of ~15.5 reflected in consensus estimates.

  • Concentration risk remains because a third of sales still derive from the largest 25 customers; any demand shock among global CPG clients would have outsized earnings impact.

  • Geographic balance is a strength; diversified regional sales reduce single-market dependency but demand heterogeneity and FX will continue to affect near-term top-line growth.

  • Operational execution around remaining integrations and innovation will be the key catalyst — watch margin expansion metrics, new product adoption among large customers, and any further divestitures or bolt-on specialty acquisitions.

For deeper counterparty analytics and tracking of customer transitions after significant divestitures, visit https://nullexposure.com/.

Bottom line and next steps for investors

IFF is executing a clear repositioning: steering away from bulk agricultural commodities into specialty ingredients and higher-margin end markets while managing transition services to ensure orderly handoffs. The completed sale of soy protein concentrate, lecithin and soy crush businesses to Bunge consummates that strategy and transfers those customer flows to a pure-play agricultural processor. Investors should focus on margin trajectory, revenue retention among top customers, and the pace of specialty growth.

Explore IFF’s customer exposures and comparable counterparty mappings at https://nullexposure.com/ to stay ahead of portfolio reconfiguration and its impact on revenue concentration and supplier criticality.